Agilon Health Inc [AGL] stock is trading at $5.18, down -3.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AGL shares have gain 27.27% over the last week, with a monthly amount glided 34.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on April 08, 2025, when Bernstein upgraded its rating to a Outperform but kept the price target unchanged to $8.50 for it. Previously, Citigroup upgraded its rating to Neutral on January 10, 2025, and elevated its price target to $2.25. On January 10, 2025, Needham initiated with a Hold rating. Macquarie started tracking the stock assigning a Neutral rating. Bernstein initiated its recommendation with a Mkt Perform and recommended $2.50 as its price target on December 11, 2024. JMP Securities downgraded its rating to Mkt Perform for this stock on November 11, 2024. In a note dated November 08, 2024, William Blair downgraded an Mkt Perform rating on this stock.
Agilon Health Inc [AGL] stock has fluctuated between $1.50 and $7.73 over the past year. Currently, Wall Street analysts expect the stock to reach $2.5 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $5.18 at the most recent close of the market. An investor can expect a potential drop of -51.74% based on the average AGL price forecast.
Analyzing the AGL fundamentals
Agilon Health Inc [NYSE:AGL] reported sales of 6.06B for the trailing twelve months, which represents a growth of 44.16%. Gross Profit Margin for this corporation currently stands at -0.0% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.42 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.94 points at the first support level, and at 4.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.56, and for the 2nd resistance point, it is at 5.94.
Ratios To Look Out For
For context, Agilon Health Inc’s Current Ratio is 1.27. Further, the Quick Ratio stands at 1.27, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 0.35, the price to book ratio is 4.53.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
